With pandemic influenza cases on the rise, federal public health authorities urged physicians to prescribe antiviral medicines to high-risk patients promptly but reminded the public that most people won't need, and shouldn't expect to get, the drugs if they come down with the flu. The guidance is aimed at getting optimal benefit from Tamiflu and Relenza while preventing overuse, hoarding, and shortages of the drugs.